Open-access publishing with author-retained rights for maximum research dissemination
Creative Commons Attribution 4.0 International (CC BY 4.0)
All articles published in JGE are distributed under the CC BY 4.0 license
What This License Permits
Share
Copy and redistribute in any medium or format
Adapt
Remix, transform, and build upon the material
Commercial Use
Use for commercial purposes with attribution
No Restrictions
Licensor cannot revoke these freedoms
Attribution Requirements
Users must provide appropriate credit when sharing, adapting, or building upon published work. Proper attribution includes citing original authors, article title, journal name, publication date, and DOI. Users should indicate if modifications were made.
Author Rights
Copyright Ownership
Authors retain full copyright ownership of published work. By submitting, authors grant JGE a non-exclusive license to publish, distribute, and archive the work. Authors may reuse their work in future publications and presentations without seeking permission.
Self-Archiving
Authors may deposit the published version in institutional repositories, preprint servers, and personal websites immediately upon publication with no embargo period.
Reuse in Future Works
Authors may reuse figures, tables, and text from their JGE publications in subsequent research articles and book chapters with proper citation.
Third-Party Content: Authors must obtain permissions for any third-party content not covered by fair use. Proof of permission should be provided during submission.
License Application
The CC BY 4.0 license applies to the published article including text, figures, tables, and supplementary materials created by authors. Third-party content included with permission retains original copyright and may have different usage terms. Authors should clearly identify any third-party content in their submissions.
Data underlying published research may be subject to different terms depending on repository policies and original data agreements. Authors should specify applicable terms in data availability statements when data sharing involves additional restrictions or conditions.
Publisher Commitments
JGE commits to maintaining published content in accessible formats, distributing articles to indexing services and repositories, preserving publications through long-term archival partnerships, and providing persistent DOI resolution. We support the scholarly communication ecosystem through participation in open science initiatives and standards development.
Authors may contact the editorial office regarding specific rights questions or requests for alternative licensing arrangements in exceptional circumstances. Standard CC BY 4.0 terms apply to all published work unless expressly modified in writing.
Derivative Works
The CC BY license permits creation of derivative works including translations, adaptations, and remixes. Educational materials, review articles, meta-analyses, and other works building on JGE publications are permitted with proper attribution. This flexibility supports knowledge transfer and application of genetic engineering research.
Commercial Applications
Commercial use of published content is permitted under CC BY 4.0 with attribution. This includes incorporation into commercial products, educational courses, and industry applications. The open license removes barriers to research translation into practical applications advancing genetic engineering biotechnology.
Best Attribution Practices
Proper attribution includes author names, article title, journal name (Journal of Genetic Engineering), publication year, volume/issue/page information, and DOI. Indicate any modifications made to original content. Attribution should be reasonable for the medium and context of reuse. When in doubt, provide more rather than less attribution detail.
Open-access licensing accelerates scientific progress by removing barriers to knowledge sharing. Your genetic engineering research reaches broader audiences, enables educational applications, and supports translation into practical benefits for society. The CC BY 4.0 license represents our commitment to open science while protecting your rights as the original author and creator of published work. This balanced approach serves both individual researchers and the broader scientific community advancing genetic engineering.
The open-access model ensures your genetic engineering research is immediately available to researchers, clinicians, industry professionals, policymakers, and the public worldwide. Removing access barriers accelerates scientific progress and supports translation of laboratory discoveries into real-world applications benefiting society.
Open licensing supports the broader goals of open science in genetic engineering research. Your work contributes to a growing body of freely accessible knowledge advancing scientific understanding and practical applications. The CC BY model represents our commitment to removing barriers while protecting your rights.
The CC BY license ensures your genetic engineering discoveries reach the widest possible audience without access barriers limiting impact.
Open access empowers research.
Public Access and Funder Compliance
Some authors are required by their funders to make their research publicly available. Under the 2024 NIH Public Access Policy, Author Accepted Manuscripts accepted for publication on or after July 1, 2025, must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official date of publication.
What JGE provides: JGE publishes the Version of Record under the Creative Commons Attribution 4.0 International licence. The journal also permits authors to deposit their Author Accepted Manuscript in funder-designated repositories. Upon acceptance, we confirm the accepted manuscript version and record the funder and grant information supplied by the authors.
Author responsibility: JGE does not currently deposit manuscripts in PubMed Central on behalf of authors. Authors are responsible for determining which funder requirements apply, initiating the appropriate repository submission and completing any required NIHMS approval steps.
Eligibility and successful processing through PubMed Central or NIHMS are determined according to the relevant funder and NIH/NLM requirements.
Important: The deposit of an individual article in PubMed Central may result in that article appearing in PubMed. It does not mean that JGE is indexed in MEDLINE, included in the PMC Journal List or that all JGE articles are available through PubMed. The journal's current coverage is listed on the Indexing page.
Editor in chief
